Bayesian Statistics Approach Offers Benefits To Sponsors, FDA Staffers Say

Use of Bayesian statistics in designing Guidant's Multi-Link Duet stent trial would have halved the number of enrollees required for FDA approval, according to Guidant Senior Biostatistician Frank Hu.

More from Archive

More from Medtech Insight